A pill has been shown to halve the risk of death from a certain type of lung cancer when taken daily after surgery to remove the tumour, according to clinical trial results presented on June 4 (2023).
The results were unveiled in Chicago, United States, at the largest annual conference of cancer specialists, hosted by the American Society for Clinical Oncology (ASCO).
Already a subscriber? Log in
Play, subscribe and stand a chance to win prizes worth over RM39,000! T&C applies.
Cancel anytime. Ad-free. Unlimited access with perks.
